Skip to main content

Medications for Lymphoma

The medications listed below are related to or used in the treatment of this condition.

Drug name Rating Reviews Activity ? Rx/OTC Pregnancy CSA Alcohol
prednisone 6.0 2 reviews for prednisone to treat Lymphoma Rx C N
Generic name:
prednisone systemic
Drug class:
glucocorticoids
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
dexamethasone 10 1 review for dexamethasone to treat Lymphoma Rx C N
Generic name:
dexamethasone systemic
Brand names:
Dexamethasone Intensol, De-Sone LA, Dxevo, HiDex, Zcort
Drug class:
glucocorticoids
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Revlimid 1.0 1 review for Revlimid to treat Lymphoma Rx X N
Generic name:
lenalidomide systemic
Drug class:
miscellaneous antineoplastics, other immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Velcade Rate Add review Rx D N
Generic name:
bortezomib systemic
Drug class:
proteasome inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
lenalidomide 1.0 1 review for lenalidomide to treat Lymphoma Rx X N
Generic name:
lenalidomide systemic
Brand name:
Revlimid
Drug class:
miscellaneous antineoplastics, other immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
bortezomib Rate Add review Rx D N
Generic name:
bortezomib systemic
Brand names:
Velcade, Boruzu
Drug class:
proteasome inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
doxorubicin 4.0 2 reviews for doxorubicin to treat Lymphoma Rx D N
Generic name:
doxorubicin systemic
Drug class:
antibiotics/antineoplastics
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Adcetris Rate Add review Rx D N X
Generic name:
brentuximab systemic
Drug class:
CD30 monoclonal antibodies
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
methotrexate 1.0 1 review for methotrexate to treat Lymphoma Rx X N X
Generic name:
methotrexate systemic
Brand name:
Trexall
Drug class:
antimetabolites, antirheumatics, antipsoriatics, other immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Leukeran 7.0 1 review for Leukeran to treat Lymphoma Rx D N
Generic name:
chlorambucil systemic
Drug class:
alkylating agents
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Trexall Rate Add review Rx X N X
Generic name:
methotrexate systemic
Drug class:
antimetabolites, antirheumatics, antipsoriatics, other immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Arranon Rate Add review Rx D N
Generic name:
nelarabine systemic
Drug class:
antimetabolites
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
brentuximab Rate Add review Rx D N X
Generic name:
brentuximab systemic
Brand name:
Adcetris
Drug class:
CD30 monoclonal antibodies
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
chlorambucil 7.0 1 review for chlorambucil to treat Lymphoma Rx D N
Generic name:
chlorambucil systemic
Brand name:
Leukeran
Drug class:
alkylating agents
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Dexamethasone Intensol Rate Add review Rx C N
Generic name:
dexamethasone systemic
Drug class:
glucocorticoids
For consumers:
dosage, interactions, side effects
Folotyn Rate Add review Rx D N
Generic name:
pralatrexate systemic
Drug class:
antimetabolites
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
nelarabine Rate Add review Rx D N
Generic name:
nelarabine systemic
Brand name:
Arranon
Drug class:
antimetabolites
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Zydelig Rate Add review Rx D N X
Generic name:
idelalisib systemic
Drug class:
PI3K inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
De-Sone LA Rate Add review Rx C N
Generic name:
dexamethasone systemic
Drug class:
glucocorticoids
For consumers:
dosage, interactions, side effects
pralatrexate Rate Add review Rx D N
Generic name:
pralatrexate systemic
Brand name:
Folotyn
Drug class:
antimetabolites
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
thiotepa Rate Add review Rx D N
Generic name:
thiotepa systemic
Brand name:
Tepadina
Drug class:
alkylating agents
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
cortisone Rate Add review Rx N N
Generic name:
cortisone systemic
Drug class:
glucocorticoids
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Dxevo Rate Add review Rx C N
Generic name:
dexamethasone systemic
Drug class:
glucocorticoids
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
HiDex Rate Add review Rx C N
Generic name:
dexamethasone systemic
Drug class:
glucocorticoids
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
idelalisib Rate Add review Rx D N X
Generic name:
idelalisib systemic
Brand name:
Zydelig
Drug class:
PI3K inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Tepadina Rate Add review Rx D N
Generic name:
thiotepa systemic
Drug class:
alkylating agents
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
vinblastine Rate Add review Rx D N
Generic name:
vinblastine systemic
Drug class:
mitotic inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Zcort Rate Add review Rx C N
Generic name:
dexamethasone systemic
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Beleodaq Rate Add review Rx D N
Generic name:
belinostat systemic
Drug class:
histone deacetylase inhibitors
For consumers:
dosage, interactions, side effects
belinostat Rate Add review Rx D N
Generic name:
belinostat systemic
Brand name:
Beleodaq
Drug class:
histone deacetylase inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Boruzu Rate Add review Rx D N
Generic name:
bortezomib systemic
Drug class:
proteasome inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Lymphir Rate Add review Rx C N
Generic name:
denileukin diftitox systemic
Drug class:
miscellaneous antineoplastics
For consumers:
dosage, interactions, side effects

Viewing all results. Return to paging

Frequently asked questions

View more FAQ

Topics under Lymphoma

Learn more about Lymphoma

Care guides

Symptoms and treatments

Legend

Rating For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).
Activity Activity is based on recent site visitor activity relative to other medications in the list.
Rx Prescription only.
OTC Over-the-counter.
Rx/OTC Prescription or Over-the-counter.
Off-label This medication may not be approved by the FDA for the treatment of this condition.
EUA An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives.
Expanded Access Expanded Access is a potential pathway for a patient with a serious or immediately life-threatening disease or condition to gain access to an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available.
Pregnancy Category
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act (CSA) Schedule
M The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication.
U CSA Schedule is unknown.
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.